Porous carbon particles for use in the treatment or prevention of liver disease

Carol Howell; Sergey Mikhalovsky; Susan Sandeman; Rajiv Jalan; Jane Macnaughtan

Porous carbon particles for use in the treatment or prevention of liver disease

Carol Howell (Inventor), Sergey Mikhalovsky (Inventor), Susan Sandeman (Inventor), Rajiv Jalan (Inventor), Jane Macnaughtan (Inventor)

Research output: Patent

Abstract

The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

Original language	English
Publication status	Published - 19 Sept 2013

Cite this

@misc{7ef224176a89423893ed6c70d5db6575,

title = "Porous carbon particles for use in the treatment or prevention of liver disease",

abstract = "The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.",

author = "Carol Howell and Sergey Mikhalovsky and Susan Sandeman and Rajiv Jalan and Jane Macnaughtan",

year = "2013",

month = sep,

day = "19",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Porous carbon particles for use in the treatment or prevention of liver disease

AU - Howell, Carol

AU - Mikhalovsky, Sergey

AU - Sandeman, Susan

AU - Jalan, Rajiv

AU - Macnaughtan, Jane

PY - 2013/9/19

Y1 - 2013/9/19

N2 - The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

AB - The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

M3 - Patent

ER -

Porous carbon particles for use in the treatment or prevention of liver disease

Abstract

Fingerprint

Cite this